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2A theoretical framework for TTO valuations and a taxonomy of
TTO approaches: results from a pilot study
1 Introduction
The economic evaluation of health care therapies has come to be dominated by Cost Utility
Analysis (CUA), usually performed estimating the incremental cost per Quality Adjusted Life
Year (QALY) gained of each option. The use of QALYs requires the valuation of each
relevant health state on a scale anchored at 1 (full health) and 0 (dead); commonly used
techniques for eliciting these valuations include Standard Gamble (SG), Time Trade-off
(TTO) and Visual Analogue Scale (VAS).
While SG is rooted in von Neumann Morgenstern utility theory (von Neumann and
Morgenstern 1944, Drummond et al 1997), the theoretical underpinnings of other valuation
methodologies are less clear. Direct valuation of health states using VAS, for example, is
widely considered to lack a theoretical basis (Johannesson et al 1996; for a contrasting view,
see Parkin and Devlin 2004). The TTO method arose not from any particular theory of utility
or utility measurement, but rather from a pragmatic desire to generate valuations with similar
empirical properties to those generated from SG, while offering a more feasible alternative to
it. By convention, TTO valuations for a given health state Hi are elicited by asking subjects to
consider t time in that state; and then establishing the (lower) number of years, x, in full
health, they would be consider equivalent; the value for Hi is given by x/t. While TTO
valuations do not conform to the utility-under-uncertainty requirements of expected utility
theory, and are therefore considered to be valuations rather than utilities per se (Drummond
et al 1997), they have nevertheless come to dominate the valuation sets routinely used in
CUA in the UK (for example, by NICE), the US and elsewhere to inform health sector
priority setting and resource allocation decisions. 
Given their widespread application in economic evaluation, the empirical properties of TTO
valuation data have been subject to extensive investigation but, arguably, there have been few
attempts to locate the approach within any particular body of theory. The aims of this paper
3are to consider the specific approach conventionally used to elicit TTO values within a body
of utility theory and, by extension, to consider what other approaches to the TTO task are also
suggested by that theory. We report results from a pilot study conducted to investigate the
feasibility of the alternative approaches and the characteristics of the valuation data generated
by them.
1.1. Hicks utility theory
Hicks (1946) describes compensated demand curves and the possibility of valuing welfare
changing events (such as changes in prices or endowments of economic goods) by
determining the compensating change in income that would return the consumer to their
original utility level. Such valuations are referred to as Compensating Variations (CV). Hicks
also describes an alternative method in which the value of a particular welfare change might
be assessed as an equivalent welfare effect achieved instead by a change in income. In this
way the focus is moved to the level of utility experienced after the change in events. These
valuations are referred to as Equivalent Variations (EV). The distinctive properties of EV
compared to CV as monetary measures of the utility affords each specific advantages in
particular contexts (Johansson 1991); both suffer from problems in aggregation for the
purpose of hypothetical compensation tests (Johansson 1991; Mishan 1971). Neither measure
can be regarded as strictly superior to the other (Ng 1979).
Both compensating and equivalent variations can be calculated for welfare gains and welfare
losses. Using the postscripts ‘G’ and ‘L’ to indicate respectively ‘gains’ and ‘losses’ in
health, this implies four valuation possibilities; CVG, CVL, EVG and EVL, as shown in
Figure 1. We use the term ‘valuand’ generically to describe the ‘thing being valued’, whether
that ‘thing’ be goods, services or intangibles. Both the CV and the EV derive from a
conceptualisation of utility space in which fixed levels of utility are associated with
combinations of commodities. The rate at which changes occur and the sequence of such
changes are assumed to be irrelevant to valuations. 
For a variety of reasons, health economists have sought alternatives to income (or wealth) as
the numeraire applied to the valuation of changes in health. Thus, Cost Benefit Analysis,
which requires monetary assessments of 'benefit', is generally eschewed in favour of CUA.
The values applied in the estimation of QALYs have used both reductions in survival
4probabilities (SG) and reductions in life expectancies (TTO) as the numeraire with which
changes in health-related quality of life (hereafter referred to as 'health') are evaluated.
Figure 1. Valuations of losses and gains by compensating and equivalent variations
The conventional TTO procedure described above can be considered as a CVG i.e., the
reduction in life expectancy (the numeraire) required to return the individual to their pre-
existing utility following a positive change (a 'gain') in health (the valuand). We have already
noted that there are no prior theoretical grounds for favouring CVG or CVL over their EV
counterparts; consequently all four valuation methods provide theoretically possible ways of
valuing a given change in health, as described below. 
The TTO as a Compensating Variation for a Health Gain (CVG): The conventional
approach to TTO (Torrance, 1976). 
The TTO as a Compensating Variation for a Loss (CVL):  We could value the same
change in health, with the same initial endowment of life expectancy, but as a reduction from
perfect health to a given state of ill health by establishing the compensating increase in
longevity required to return the individual to their original level of utility. CVL and CVG
cover different areas in utility space and there is no reason to suppose that the valuations
would be equal (see Figures 2a and 2b).
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5Figure 2a. Figure 2b
CV & EV applied to the same gain in CV &EV applied to the same loss in
health health
The TTO as an Equivalent Variation for a Gain (EVG): The possibility of using an
equivalent variation to value an improvement in health was suggested by Buckingham
(1995). An equivalent variation for a gain in health would attempt to determine the increase
in life expectancy that would take the respondent to the same (higher) utility level as the
increase in health. Careful inspection of Figures 2a and 2b will show that the utility space
that such a question spans is identical to that spanned by the compensating variation for the
same change in health viewed as a health loss (CVL). In the absence of any framing effects
(e.g., resulting from the valuation of a loss as opposed to an identical gain – we discuss a
number of such effects in Section 1.2), there is no reason a priori to expect that the valuations
yielded by EVG and CVL would be different.
The TTO as an Equivalent Variation for a Loss (EVL): An equivalent variation valuation
of a reduction in health over the same range is also possible and spans the same utility space
as the conventional compensating variation valuation of a health gain (CVG). Thus, again in
the absence of framing effects, we would expect these measures to produce the same
valuation.
Note that under some TTO protocols a starting point combination of life expectancy and
health state is deliberately not specified to avoid any ‘endowment effect’. In the absence of
such a starting point the classification of technique as either CVG or EVL is indeterminate,
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6since the question of whether we are considering alternative ways of obtaining a different
level of utility i.e., EV, or returning to a prior level of utility ie CV is avoided. Nevertheless,
we would argue that the approach is still fundamentally Hicksian, since the aim is to identify
points of indifference to achieve valuations. 
1.2 The calculation and interpretation of a health state index
The application of Hicksian welfare theory to health is somewhat different from its more
familiar uses, most obviously because tradeoffs are sought in terms of life years rather than
money. More fundamentally, the ultimate aim is to produce health state indices rather than
simply valuing welfare changes. In Figure 3 (an alternative representation of the information
conveyed using indifference curves) we see the change from fair health to perfect health is
compensated by a reduction in life expectancy from 10 years to 6 years. The compensating
variation would thus be 4 years. Two additional steps are required to convert this
compensating variation into an index. (Analogous procedures are necessary for equivalent
variations.)
Firstly we must assume that utility is proportional to time spent in perfect health. Arbitrarily
we define our measure of utility, such that 1 year in perfect health is equal to 1 ‘util’. With
proportionality x years in perfect health is equivalent to x utils. In Figure 3, we see that 10
years in fair health has the same utility as 6 years in perfect health, and hence the utility of 10
years in fair health is 6 utils.
One final step is required to arrive at an index. A requirement of the index is that it can be
multiplied by time to construct QALYs where QALYs are used as a proxy measure of utility.
The only possible interpretation of something that we multiply by time to produce a measure
of utility is that it is a flow of utility per period of time. To convert our proxy for the absolute
value of utility of fair health for 10 years, into an average flow of utility over those years, we
must divide it by the time taken to achieve the utility. Thus in our illustrated example, the
index is (6 utils)/(10 years) or 0.6 utils per year. 
7Figure 3. The application of proportionality in constructing a health index
Note that if this value is to be applicable to different time periods, we must make a further
proportionality assumption. We must now assume that utility is proportional to the time spent
in the state of health that has been valued for all life expectancies. Unless this were the case,
the average flow for any given period would not necessarily be applicable to other periods. In
Figure 3, we show a non- linear relationship for fair health such that utility is not proportional
to the time spent in that state. If we were to try to estimate the utility of 5 years in fair health
by multiplying those 5  
years by our index of 0.6, we would estimate the value of 5 years in fair health as 3 utils. In
Figure 3 the utility shown is actually 4 utils, i.e. the QALY value (product of the index
multiplied by time) gives an incorrect estimate of utility. 
Thus, to generate a TTO index that is applicable to all time periods, we need to employ the
assumption of proportionality twice. Firstly, in assuming proportionality at perfect health, and
secondly assuming proportionality at less than perfect health i.e., corresponding to the two
lines shown n Figure 3.
Note that the Standard Gamble also needs to employ two proportionality assumptions to
produce an index, but the first of those assumptions is proportionality of utility to probability
rather than time. This is used to value the health state. The assumption of proportionality of
utility to time in the health state being valued is subsequently used to convert the value of that
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8health state into an index. These two steps may be masked by the scaling assumptions used to
construct the Standard Gamble. 
1.3 Recent TTO research in the context of this theoretical framework
Alternative formulations of the TTO task have received increasing attention in the literature.
In this section we review recent empirical work on TTO with the purpose of (a) placing these
findings in the context our theoretical model and (b) deriving hypotheses relevant to the
characteristics of individuals’ utility functions between health and length of life that might be
explored in a pilot study of the four approaches we describe above.
Empirical studies have usually revealed differences in the TTO valuations given to health
states when alternative formats of the valuation task are used. The most described effect is
that of time preference. For example, Dolan and Gudex (1995) attempted to separate the
effects of time preference from that of duration and concluded that TTO is not suitable for the
valuation of short duration health states where the life expectancy presented is unrealistic to
the respondent.
The conventional (CVG) TTO valuation assumes linear increases in utility for time spent in
perfect health. SG does not assume this linearity and this has been used to explain why
elicited TTO valuations are lower than SG valuations for the same state. Consistent valuation
over the full range of health states assumes a constant proportional trade off. Dolan and
Stalmeier (2003) concluded that this may not always be the case for ‘poor’ health states,
where subjects may not wish to extend life, and for long durations of time where time
preference becomes a significant factor. The assumption of linearity in utility for duration
intuitively does not hold for states of severe health where increasing duration in a poor health
state may be valued less highly than a shorter duration of life in a (marginally) better health
state. Sutherland et al (1982) explored this relationship using a certainty equivalence method
and found that as duration of survival increased or the health state being valued became more
severe, more subjects preferred immediate death to survival in a state of very poor health.
This is the concept of ‘maximal endurable time’, which is dependent on the state of health
under consideration. 
Bleichrodt (2002) describes other biases that affect the valuation processes of SG and TTO in
addition to the effect that time preference has on the shape of individual indifference curves.
Probability weighting affects valuations obtained by SG, in that subjects evaluate probability
9as an ‘s’-shaped function (and not as a linear function), under-weighting small probabilities
and over-weighting large probabilities. SG valuations will reflect this weighting, whereas
TTO valuations, which are elicited under conditions of certainty, do not.
Loss aversion - the tendency to value losses more highly than equally-sized gains (Kahneman
and Tversky 1991) - has been demonstrated to exert important effects on both SG and TTO
valuations, suggesting that the starting or 'reference' point for the valuation is particularly
important. The reluctance to sacrifice length of life in order to improve health in the
conventional TTO (CVG) question (an upward bias in valuation) should be reversed if the
subject is asked a ‘reverse’ of the TTO question (CVL) i.e., what number of years in a poor
health state is equivalent to a fixed number of years in full health.
Spencer (2003) and Clarke et al (2003) have investigated the effects of altering the reference
point of the subject on the valuations of health states. Spencer (2003) investigated valuation
using an ‘unconventional’ TTO approach where subjects were asked to imagine living in a
health state (less than full health) for a period of two years, followed by death. They were
then asked to trade by prolonging life in a lower quality health state. The health states
evaluated in this way were EQ-5D states 21222 and 22232. Figure 4 shows that this is
effectively, in terms of the theoretical framework introduced in Section 1.1, a compensating
variation for a health loss (CVL). 
Figure 4. Spencer’s (2003) ‘unconventional TTO’. 
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The values obtained for the milder of these two states using Spencer's  'unconventional'
approach were significantly lower than the values obtained in the conventional (CVG)
manner. However the valuations produced may have been affected by the short duration of
time used in this TTO experiment. Short time periods have been shown to affect the
willingness of subjects to trade time for quality of life, although most studies reported using
short durations relate to palliative care for cancer, e.g., McNeil et al (1981). 
Clarke et al (2003) also consider the effect of the valuation reference point and describe the
‘unconventional’ TTO as a time gain, where subjects start in full health with an endowment
of time and gain time in order to compensate for a reduction in health. Again, this is, in our
theoretical framework, a CVL. Valuations were elicited by questionnaire using EQ-5D health
states 11122 and 22222 and the amounts of time that could be traded were pre-specified.
Results showed that subjects may produce inconsistent valuations when asked to value states
from different reference points. 
Bleichrodt et al (2003) also found violations of consistency at low durations when testing an
alternative version of TTO. This study consisted of two stages. Stage one was a conventional
TTO (CVG in our taxonomy) in which life expectancy was exchanged for an improvement in
health. Stage 2 was ‘reflexive’, in that respondents were asked to consider starting in full
health and with the reduced life expectancy determined in stage 1 and were asked what
extension in life expectancy they would require as compensation for a reduction in health to
the level of ill health specified in stage 1 (see Figure 5). The elicitation of values in each
stage was separated by a gap of at least two weeks. In theory, the subjects should return to the
duration in the state of poor health presented in the first question since the individual biases
referred to above should apply in reverse when the question is reversed, i.e. the valuations
should be ‘reflexive’. In particular, when compared with SG valuations, the inconsistencies
found at lower durations could be predicted by loss aversion. Longer durations within the
questions elicited TTO valuations from both types of question that exceeded SG valuations
for the same health states.
Thus, while a number of recent contributions to the literature have considered alternative
formulations of the TTO procedure, most - including Spencer (2003), Clarke (2003) and
Bleichrodt (2003) constitute use of a CVL. As far as we can determine, none of the existing
contributions to the literature recognise the CVG and the CVL as part of a wider class of
11
valuation approaches suggested by Hicks utility theory, and none propose or investigate the
equally plausible set of approaches suggested by the EV
Figure 5. Bleichrodt’s (2003) “reflexive” TTO.
. 
Existing research does, however, suggest a number of factors to be considered in empirical
testing of the four approaches described in Section 1.1. First, the importance of time
preference in TTO valuations is expected to exert an influence on the valuation for a given
state generated using either CVG and EVL – where the values the numeraire (life
expectancy) can take are effectively "bounded" by the initial "reference point" life
expectancy against which tradeoffs are made – compared to the valuations for that same state
generated by either the CVL or EVG, where the numeraire is unbounded.  Second, and also
in relation to the "unboundedness" of the numeraire in CVL and EVG, Sutherland’s (1982)
concept of maximal endurable time may have implications for the nature of the preferences
that are evident by testing and comparing all four approaches. Third, prospect theory suggests
that gains and losses may be valued asymmetrically, suggesting the value assigned to a given
state may be influenced by whether that state is framed as a gain or a loss from an initial
reference point.  
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2 The pilot study
2.1.    Aims of the pilot study
From the theoretical framework described above, a pilot study was developed with the
following aims: 
(a) To investigate the feasibility of valuing health states using EV approaches. 
(b) To investigate whether the valuations for a set of health states differ statistically between
the four valuation approaches. 
(c) To explore intra-rater variation in health state valuations between each approach
(d) To generate insights, via both quantitative and qualitative analysis to facilitate further
research.
2.2.  Pilot methods and sample
An interview protocol was developed to elicit valuations for three EQ-5Di health states:
22222 ("some problems" with mobility, self-care, usual activities, pain/discomfort and
anxiety/depression respectively), 11211 ("some problems" with usual activities; no problems
on any of the other dimensions) and 11121 ("some problems" with pain/discomfort; no
problems on any of the other dimensions). EQ-5D states were chosen to facilitate comparison
of our results with those from the MVH study (Dolan 1996), TTO values from which are
widely used in economic evaluation in the UK. Mild states were selected in the light of
Sutherland's (1982) findings and also because, given the necessity for us to develop
fundamentally new valuation 'props' for this study, we wished to avoid the possibility of
states being evaluated as being 'worse than dead' which, in the TTO, requires the interviewer
to administer a separate valuation procedure (Drummond et al 1997). Questions were
developed to address both CV and EV variants of TTO for both health gain and loss. Pre-
testing of the EV questions was undertaken on a small sample of students at the University of
Otago. This led us to include the following question in the pilot study, in order to investigate
the issue of constant proportionality and monotonicity in the relationship between time and
utility: 
 ‘Can you imagine a state of poor health such that, although you would choose to
live in that state of health for a short period of time (say one year) rather than die
immediately, you would prefer not to live in such a state of health for a long time
(say 20 years)?’
The valuation of health states in response to TTO is made by calculating x/t at the point of
indifference, where x is the length of time in full health and t is the length of time in the state
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for which the valuation is sought. In the pilot interview the four approaches to TTO question
ask the subject to vary x and t as shown in Table 1.
Table 1. Variation of x or t by TTO approach and calculation for x/t where the fixed
value is 10 years.
x t x/t
CVG variable fixed x/10
CVL fixed variable 10/t
EVG fixed variable 10/t
EVL variable fixed x/10
2.3  Interview design and visual aids
A single TTO board, based on that used in the MVH study but with additional features, was
developed such that all four valuation approaches could be demonstrated. Particular attention
was given to the wording of questions. EV considers equivalent moves to a new level of
utility. Linguistically and logically this is represented by an ‘OR’. Thus, for example, in
framing an EVG question, we ask questions such as, ‘You have the choice of an
improvement in health OR an improvement in length of life, which would you choose?’;
length of life being varied to determine equivalence. In contrast, CV considers changes that
involve a return to the original level of utility. Linguistically and logically this is represented
by an ‘AND’ statement. Thus, for example, in framing a CVG question we ask questions
such as, ‘You face the possibility of an improvement in health AND a reduction in length of
life; how much of a reduction in length of life would you be prepared to accept?'
Each interview started with a brief introduction, describing the type of questions that would
be included. Anonymity was assured and consent to tape the conversation, in order to obtain
qualitative data, was obtained. The valuation exercise commenced with the question
described above. Subjects were then asked to rank the three EQ-5D states to be evaluated, in
order to check their understanding of the descriptions and to provide a means of checking the
consistency of their subsequent valuations with these rankings. Each of the three states was
then valued using each of the four TTO approaches, yielding 12 valuation tasks per interview.
To avoid ordering effects the tasks were ordered by random draw for each interview. 
A convenience sample of 50 subjects was recruited from students at City University, staff at a
pharmaceutical company and personal contacts. Subjects were also asked to provide some
demographic data, (Table 2). Due to its nature the sample is unrepresentative of the general
14
population in terms of age and education. This should be borne in mind in the interpretation
of the results.
3 Pilot study results 
Demographic characteristics of the participants are shown in Table 2.
Table 2. Characteristics of the respondents
Number Percentage
Age
< 20 0 0%
20-25 3 6%
26-30 8 16%
31-35 17 34%
36-40 9 18%
41-50 5 10%
51-60 1 2%
61-70 2 4%
71-80 0 0%
> 80 5 10%
Sex
Male 25 50%
Female 25 50%
Educational attainment
Minimum secondary education 3 6%
All secondary education 7 14%
First degree 16 32%
Postgraduate degree/ Professional Qualification 24 48%
Experience of serious illness in last two years
Yes 22 44%
No 28 56%
 3.1 Feasibility 
The order of questions in each interview was chosen by random draw. In practice some
question formats were harder for subjects to understand than others, particularly where the
initial question was in the CVL format when compared to an ordering where this type of
question was asked for the first time later in the interview. The easiest formats appeared to be
the CVG and the EVL. Both approaches have a similar output: a trade of a reduction in time
to achieve full health, but whereas the CVG finds the change in duration required to return
subjects to their initial utility level, EVL seeks the change in life expectancy required to
achieve a new utility level. Subjects' comments on the tasks, and the differences in their
valuation of the same states between valuation approaches, suggest that subjects generally
were conscious of differences between the tasks they were asked to complete. 
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3.1.1. Non-trading responses
Two types of non-trading response to TTO questions were observed during the interviews:
(a) A refusal to decrease time in full health in the CVG and EVL questions; and
(b) A refusal to increase the number of years in a poor health state in the CVL and EVG
questions.
The conventional interpretation of the former case, is that subjects do not trade are effectively
saying that the health state being valued is equivalent to full health. In the analysis this type
of response is included as a value = 1. In the latter case subjects are stating that no increase in
time could compensate for, or be considered equivalent to, the change respectively to (CVL)
or from (EVG) the poor state of health; for the purposes of the following analyses, these were
assigned a value = 0ii. This latter type of non-trade was more common in evaluations of state
22222. In the EVG question, where the choice is between increased health or increased time,
only 20 subjects were prepared to trade time for 22222, with 30 refusing to trade. Rates of
non-trading responses are summarised in Table 3 below.
Table 3. Rates of non-trading response to TTO questions by question type and health
state.
Health State 11211 11121 22222
Non-trade type (a): State equivalent to full health
CVG number of subjects 21 19 1
percentage of subjects 42% 38% 2%
EVL number of subjects 15 16 5
percentage of subjects 30% 32% 10%
Non-trade type (b): due to perceived severity of state
CVL number of subjects 6 4 21
percentage of subjects 12% 8% 42%
EVG number of subjects 8 9 30
percentage of subjects 16% 18% 60%
The rates of both types of non-trading response were affected by the state under valuation, the
participant’s interpretation of the state and the perception of all three states in the interview. 
3.2. Valuation results
3.2.1. Initial question on monotonicity of the utility time relationship
48 of 50 subjects interviewed (96%) answered yes to the question: ‘Can you imagine a state
of poor health such that, although you would choose to live in that state of health for a short
16
period of time (say one year) rather than die immediately, you would prefer not to live in
such a state of health for a long time (say 20 years)?’
3.2.2.  Individual ordering of health states for valuation
In their initial ranking of the three states, all subjects indicated that state 22222 was the least
preferred. 
Table 4. Initial ranking of health states
Order of states Number Percentage
11211, 11121, 22222 28 56%
11121, 11211, 22222 22 44%
This difference in ordering is reflected in the summary statistics, where the mean valuations
for these two states are similar.
3.2.3. Consistency in individual ordering of health states
Intra-rater reliability was tested by examining whether the order of the valuations for each
state given by individual subjects was consistent with their initial ranking of the states.
Subjects initially rating state 11211 > 11121 gave the following order of valuations within the
interview (see Table 5). 
Table 5. Consistency of valuations with ordering for 28 subjects initially rating state
11211>11121
Method of
valuation
Order consistent
with initial rating
Valuations equal Order reversed
from initial
valuation
n % n % n %
CVG 10 36% 9 32% 9 32%
CVL 13 46% 6 21% 9 32%
EVG 11 39% 6 21% 11 39%
EVL 17 61% 4 14% 7 25%
Similarly, subjects who initially ranked 11121 > 11211 had levels of consistency as shown in
Table 6.
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Table 6. Consistency of valuations with ordering for 22 subjects initially rating state
11121>11211
Method of
valuation
Order consistent
with initial rating
Valuations equal Order reversed
from initial
valuation
n % n % n %
CVG 6 27% 8 36% 8 36%
CVL 11 50% 5 23% 6 27%
EVG 7 32% 8 36% 7 32%
EVL 8 36% 8 36% 6 27%
Many subjects reversed their initial rating of these two states within the main body of the
interview; others rated the states as being equal. This, together with the fact that the states
were not ordered consistently between the 4 valuation approaches, probably reflects the near
equivalence of these two states, rather than indicating difficulties with the interview process
itself. 
3.3. Summary statistics for the valuations
The distribution of valuations for each health state and each valuation type are shown in the
appendix. The effect on the distribution caused by non-traders for the CVL and EVG
methods is visible, especially for the state 22222. At least one of the distributions for the
valuations of the two mild health states, 11211 and 11121, are highly skewed. Medians and
ranges for valuations of each state using each method are provided in Table 7. 
Table 7. Median and range of sample valuations for each health state and TTO variant
Health State 11211 11121 22222
CVG median 0.90 0.90 0.60
minimum 0.50 0.50 0.20
maximum 1.00 1.00 1.00
range 0.50 0.50 0.80
CVL median 0.77 0.77 0.40
minimum 0 0 0
maximum 1.00 1.00 1.00
range 1.00 1.00 1.00
EVG median 0.74 0.77 0.00
minimum 0.00 0.00 0.00
maximum 1.00 1.00 1.00
range 1.00 1.00 1.00
EVL median 0.90 0.90 0.60
minimum 0.50 0.40 0.20
maximum 1.00 1.00 1.00
range 0.50 0.60 0.80
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The median valuations are lower for the two mild states when the subjects are asked to vary t
(CVL and EVG) when compared to questions where x is varied (CVG and EVL). In the
valuation of the state 22222, the median valuations are higher for the questions where t is
varied than for those where x is varied. 
The median valuations for the states 11211 and 11121 are all identical except for those
generated by the EVG approach. This would be expected given the results shown above for
the group where 28 subjects ranked the state 11211 as more preferred to 11121 and 22
subjects ranked these states in the reverse order.
The mean and standard deviation from the mean for each health state and each type of TTO
question are shown in Table 8. Non-trading responses are included in the analysis as
described above. All groups therefore contain 50 responses. 
Table 8.  Mean (standard deviation) and number of observations for each health state
by TTO approach.
Health State 11211 11121 22222
CVG mean (sd) 0.88 (0.15) 0.86 (0.16) 0.60 (0.19)
CVL mean (sd) 0.68 (0.28) 0.71 (0.24) 0.38 (0.36)
EVG mean (sd) 0.63 (0.32) 0.63 (0.34) 0.28 (0.36)
EVL mean (sd) 0.86 (0.14) 0.82 (0.18) 0.61 (0.21)
Again the mean valuations for the states 11211 and 11121 are similar, as expected from the
ordering of states described above.
The skewed nature of the distribution of the valuations obtained in this study means that non-
parametric testing between the groups of valuations is required. The valuations for each
variant of the TTO question for a given health state were compared, using a two sample
Wilcoxon rank-sum test. Analysis was carried out using Stata version 8.0 (Stata corporation,
Texas). The following results were obtained from comparison of the groups.
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Table 9. Pair-wise comparison of valuation methods for a given health state. 
Health State Pair-wise
comparison
Z statistic probability
11211 CVG vs. CVL 4.655 <0.001
CVG vs. EVG 4.825 <0.001
CVG vs. EVL 0.977 0.33
CVL vs. EVG 0.701 0.48
CVL vs. EVL -3.888 <0.001
EVG vs. EVL -4.230 <0.001
11121 CVG vs. CVL 3.868 <0.001
CVG vs. EVG 4.041 <0.001
CVG vs. EVL 1.031 0.30
CVL vs. EVG 0.430 0.66
CVL vs. EVL -2.748 0.006
EVG vs. EVL -3.057 0.002
22222 CVG vs. CVL 2.897 0.004
CVG vs. EVG 4.248 <0.001
CVG vs. EVL 0.059 0.95
CVL vs. EVG 1.385 0.17
CVL vs. EVL -2.949 0.003
EVG vs. EVL 1.964 <0.001
All comparisons except those between the CVG and EVL methods and between the CVL and
EVG methods were significant at the 5% level. These are the results predicted from the utility
map (Figures 2a and 2b), since valuations made by the CVG method cover the same utility
space as those conducted by EVL. The same is true for valuations conducted by the CVL and
EVG methods.
The conventional (i.e., CVG) TTO approach used in this pilot facilitates comparisons of these
valuations with those from the MVH study (Dolan, 1996) – see Table 10. 
Table 10: Comparison of study valuations for CVG TTO with those from the MVH
tariff.
Health State CVG Valuation MVH Tariff Value
11211 0.88 0.84
11121 0.86 0.83
22222 0.60 0.49
4 Discussion
This paper has reported on a preliminary examination of the four alternative ways of valuing
the same change in health with the same initial endowment of life expectancy. Given that
there are no theoretical grounds for asserting the primacy of one method over another, the
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choice of technique is an empirical matter and should rest on issues of acceptability, bias and
reliability. There was no indication from our discussions with participants that any of the
methods was unacceptable, although some commented on the ‘oddness’ of EVG and CVL
questions: 
‘It’s a peculiar compensation, isn’t it, I’ve got pain, so I want more life…’
Participants also had some difficulty when the randomisation process in our research design
meant that all or most types of valuation question for the same state were clustered together.
For example, one participant, asked the EVL and CVG questions sequentially for the same
state, commented:
“ This is the same question, one year, I’ve already answered this one”
Subjects were also concerned with the ‘correctness’ and consistency of their valuations; some
attempted to value the same state consistently between methods.
“ I’m sure we’ve already done this question, what did I say last time? I think seven,
so seven is the right answer”
In the absence of a gold standard measure of utility, the question of bias is difficult to
determine. Older and younger respondents made comments that indicated their views on time
preference were, predictably, rather different and this may have affected the valuations for
EVG and CVL, where the equivalent or compensating change in life years in less than full
health is unbounded. While, as we have noted, there was a considerable proportion of non-
traders on the EVG and CVL, comments from those who did trade made comments that
indicate their values were affected by their views about the future:
“ That would give me an extra 20 years, but it would mean that I would stay in pain,
but I think I would rather live longer and hope that there would be more treatment
out there that would help my pain in future”.
Reliability might be inferred from the variability in the answers that people gave for the same
state of health. The variability of responses, as judged by the standard deviations of the
estimated mean values ascribed to the health states, did not differ appreciably between
methods.
The most significant finding relates to the use of the approaches that ask people to consider
extensions in life expectancy, either as an alternative to a health gain (EVG) or as a
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compensation for a health loss (CVL). Two key pieces of evidence from our pilot suggest a
relationship between length of life and utility that is non proportional and even non
monotonic for some states of health. 
First, a substantial proportion of our sample was insufficiently attracted by the possibility of
longer life in poor health to trade. This was particularly the case with state 22222:
“…the thought of going longer in that state is not good”
Second, 96% of respondents responded positively when asked “Can you imagine a state of
poor health such that, although you would choose to live in that state of health for a short
period of time (say one year) rather than die immediately, you would prefer not to live in
such a state of health for a long time (say 20 years)? 
Taken together, these findings suggest the possibility of utility functions in length of life of
the general form illustrated in Figure 6a. 
Figure 6a. Utility as a function of length of
life
Figure 6b. Indifference curves in health
and length of life
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In perfect health we assume that utility never declines with increasing length of life. In such
states of health, we might like to live forever. At some ‘poor’ states of health utility increases
then decreases. We would like to live for some time in such states, but not forever. Where
this is the case, our representation of utility as a function of time is non-monotonic attaining a
maximum value (an inverted ‘u-shape’). Some ‘extremely poor’ states of health are shown
such that utility invariably decreases with length of life. We would prefer to die immediately
rather than endure such states. These states are unambiguously worse than death. Figure 6b
illustrates the same relationship in the form of indifference curves.iii
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Figure 6b helps us to understand and interpret some of the results from the four valuation
procedures when considering those poor states of health for which a maximal endurable time
exists. Such a utility mapping would have the following implications:
(a) Equivalent variations of a health-related quality of life gain may well be unstable or even
indeterminate at low quality of life levels. 
(b) There is no single health state that can be described as a ‘state worse than death’. It
depends upon the duration of the state. This is illustrated by the line showing, for any given
health state, the maximum total utility possible in increasing length of life – the ‘maximal
desirable length of life’. Beyond this point, in any given state of health, increased length of
life is detrimental to utility.
(c) Although not so unstable as the equivalent variation, compensating variations may also be
unstable when considering poor states of health.
These results pose a fundamental challenge to the appropriateness of the constant
proportionality assumptions invoked in the estimation of TTO values and their application in
CUA. If utility accumulates at different rates as length of life changes, a single value for any
given state, independent of its duration, is not tenable.
There is no simple way out of this dilemma. Theoretically, if we knew exactly how utility
varied with life expectancy, it might be possible to integrate a time utility functioniv. At
present, when calculating QALYs, we simply ignore the problem. This latter may be a
reasonable approximation if we are considering relatively lengthy time periods, and if the
anomalies in the time utility are no more than ‘local disturbances’ applying to short time
frames, with reasonable stability over longer periods.
If our aim is to produce an index by dividing an estimate of the utility of some combination
of health state and length of life, by the time over which that utility is accrued, then it may be
preferable to control that length of life in constructing the question. The CVG and the EVL
both value a specified life expectancy in poor health and trade time in good health. The CVL
and the EVG effectively value a variable time in poor health using a specified time in good
health. This implies poor control over the thing being valued. Moreover, the findings from
our pilot study suggest that, even in intermediate states of health, it may not be possible to
extend the time in poor health sufficiently to achieve a change equal to perfect health. We
need to explore whether this problem arises if we start with much shorter life expectancies. It
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is likely that more people would be content to live longer in poor health if the choice was
between that and a very short life in perfect health. 
More work is needed to explore these issues. In the meantime, we should not assume that the
conventional TTO is applicable to a wide range of life expectancies. It appears that even
moderate states of health may be dispreferred to death over long durations.
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Appendix
Frequency Distribution for Valuations of Health State 11211
Frequency Distribution for Valuations of Health State 11121
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Distribution of Valuations: CVL
0
5
10
15
20
25
0
0.3
0
0.3
5
0.4
5
0.5
3
0.5
9
0.6
3
0.6
7
0.7
0
0.7
4
0.7
7
0.8
3
0.8
7
0.9
1
1.0
0
Valuation
Fr
eq
ue
nc
y
Distribution of Valuations: EVG
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Distribution of Valuations: EVL
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Distribution of Valuations: CVG
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Distribution of Valuations: EVG
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Distribution of Valuations:CVL
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Distribution of Valuations: EVL
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Frequency Distribution for Valuations of Health State 22222
                                                
i The EQ-5D is an instrument for describing health states. Health state are described in terms of 3 levels (‘no’,
‘some’ or ‘extreme’ problems, coded as 1,2 and 3 respectively) on five dimensions (mobility, self-care, usual
activities, pain/discomfort and anxiety/depression. The EQ-5D describes 243 unique states, each identified by a
five digit number (e.g. 21111) according to the levels within each of the dimensions, in the specific order listed
above.
ii Including these non-trades at 0 assumes that these states were considered ‘at least as bad as’ dead, given that
the scale of values is anchored at dead = 0 and full health = 1. This may impose be an upward bias on mean
values for the states concerned, but was considered preferable to the bias introduced by excluding these
valuations.
iii Figures 6a and 6b were produced using the same parameters in a function of the general form
U = aHL - bL - cL2 where U = Utility, H = Health and L = Length of life.
iv Alternatively we could use a composite value such as a HYE to aggregate the utility of individual length of
life/quality of life combinations. The use of HYEs in this way would, however, require a large research effort to
construct a tariff of values for the multiplicity of possible health profiles rather than a tariff for health states.
Distribution of Valuations: CVG
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Distribution of Valuations: EVG
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Distribution of Valuations: CVL
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Distribution of Valuations: EVL
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